Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1988-6-29
|
pubmed:abstractText |
The aim of the present study was to assess the clinical efficacy and safety of a new H2-antagonist, nizatidine (N), administered as a single bedtime dose of 300 mg, compared with ranitidine (R) at the same dosage, in the short-term treatment of duodenal ulcer. One hundred forty one patients were included in the study: 70 were treated with N and 71 with R. During the study, three patients were withdrawn for unwanted effects not related to the treatment, and therefore, 69 patients per group were studied. After 4 wk of treatment, 58 patients treated with N (84.1%) and 55 in the group treated with R (77.5%), showed complete endoscopic ulcer healing (p greater than 0.5). The corresponding figure after 8 wk of therapy was 64 (94.2%) and 65 (94.2%) (p greater than 0.5). A similar effect on pain relief was observed: 42% of patients in both groups became asymptomatic after 4 wk. After 8 wk, the percentage rose to 84.2% in the group treated with N and 87.0% in the R group (p greater than 0.5). In both groups, only minor side effects occurred, not requiring drug discontinuation. These data show that nizatidine in a single bedtime dose of 300 mg is as effective and safe as ranitidine at the same dosage, and represents therefore a valid alternative to the usual H2-antagonists.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0002-9270
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
643-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2897784-Adolescent,
pubmed-meshheading:2897784-Adult,
pubmed-meshheading:2897784-Aged,
pubmed-meshheading:2897784-Clinical Trials as Topic,
pubmed-meshheading:2897784-Double-Blind Method,
pubmed-meshheading:2897784-Drug Administration Schedule,
pubmed-meshheading:2897784-Duodenal Ulcer,
pubmed-meshheading:2897784-Female,
pubmed-meshheading:2897784-Histamine H2 Antagonists,
pubmed-meshheading:2897784-Humans,
pubmed-meshheading:2897784-Male,
pubmed-meshheading:2897784-Middle Aged,
pubmed-meshheading:2897784-Nizatidine,
pubmed-meshheading:2897784-Ranitidine,
pubmed-meshheading:2897784-Thiazoles
|
pubmed:year |
1988
|
pubmed:articleTitle |
Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
|
pubmed:affiliation |
Gastrointestinal Unit, Ospedale L. Sacco, Milano, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|